Andere Sprachen Zenith Capital Corp.

Aktien

A2APXB

CA98935N1033

ZHCLF

Markt geschlossen - OTC Markets Andere Börsenplätze 19:10:50 01.05.2024			% 5 Tage	% 1. Jan.
0,1 ^USD	-60,00 %		-50,00 %	-16,67 %

05.04.	Zenith Capital Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024	CI
2023	Zenith Capital Corp. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Oktober 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	05.04.
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	23.12.
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023	28.09.23
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023	29.08.23
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type	01.06.23
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	06.04.23
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	24.12.22
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	30.09.22
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	15.09.22
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	15.09.22
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial	10.05.22
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01.04.22
Zenith Epigenetics Provides Clinical Update	31.01.22
Zenith Epigenetics Announces Changes to Board of Directors	31.01.22
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	20.12.21
Newsoara BioPharma Co., Ltd. announced that it expects to receive $1.5 million in funding from Zenith Capital Corp.	15.11.21
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2021	31.08.21
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	30.08.21
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer	24.06.21
Zenith Epigenetics Announces Clinical Collaboration with Astellas	22.04.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zenith Capital Corp.

Aktien

A2APXB

CA98935N1033

ZHCLF

Andere Sprachen

Filter